Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

NIPRIDE RTU IN SODIUM CHLORIDE 0.9%

SODIUM NITROPRUSSIDE

Standard Dose
10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview NIPRIDE RTU IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 209387 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient SODIUM NITROPRUSSIDE Form and strength SOLUTION;INTRAVENOUS - 10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EXELA PHARMA Submission history Latest submission status date: 2018-07-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview NIPRIDE RTU IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 209387 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient SODIUM NITROPRUSSIDE Form and strength SOLUTION;INTRAVENOUS - 10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor EXELA PHARMA Submission history Latest submission status date: 2018-07-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.